secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2021-10-15T23:59:59+00:00
Accession:  0001493152-21-025492
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics prices $7.9M public offering, uplists to Nasdaq, effects 1-for-2.5 reverse split
--------------------------------------------------------------------------------

- Offering of 1,510,455 units at $5.25/unit raised $7.9M gross; units consist of 1 share + 1 warrant (strike $6.30, 5-year term).
- Common stock and warrants began trading on Nasdaq Capital Market Oct 13 under symbols BBLG and BBLGW.
- Company effected 1-for-2.5 reverse stock split effective Oct 12, 2021.
- Underwriters granted 45-day over-allotment option for up to 226,568 additional shares and/or warrants.
- WallachBeth Capital acted as sole book-running manager; closing expected Oct 15, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315221025492/0001493152-21-025492-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315221025492/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-025492

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer